Charles Yu

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

Florian von Groote-Bidlingmaier, R. F. Patientia, Epifanio Sánchez et al. · The Lancet Respiratory Medicine · 2019 · 163 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han et al. · The Lancet · 2022 · 113 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

Humberto Reynales, Airi Põder, Charles Yu et al. · The Lancet Infectious Diseases · 2021 · 48 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study

Erik Buntinx, L Brochado, Charissa Borja-Tabora et al. · Vaccine · 2023 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

An independent, multi-country head-to-head accuracy comparison of automated chest x-ray algorithms for the triage of pulmonary tuberculosis

William Worodria, Robert Castro, Sandra V. Kik et al. · medRxiv · 2024 · 12 citations · Full text

Medicine, Health Informatics, Infectious Diseases +17